Prognostic factors and the prognostic role of inflammation indices in malignant pleural mesothelioma

被引:1
|
作者
Ebinc, Senar [1 ]
Oruc, Zeynep [1 ]
Kalkan, Ziya [1 ]
Karhan, Ogur [1 ]
Urakci, Zuhat [1 ]
Kucukoner, Mehmet [1 ]
Kaplan, Muhammet Ali [1 ]
Abdurrahman, Isikdogan [1 ]
机构
[1] Dicle Univ, Fac Med, Dept Internal Med, Div Med Oncol, Diyarbakir, Turkiye
来源
TURK GOGUS KALP DAMAR CERRAHISI DERGISI-TURKISH JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY | 2023年 / 31卷 / 01期
关键词
Inflammation indices; malignant pleural mesothelioma; prognostic nutritional index; prognostic score; SURVIVAL; CANCER; RATIO; LYMPHOCYTE; PARAMETERS;
D O I
10.5606/tgkdc.dergisi.2023.23365
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background: In this study, we aimed to investigate the prognostic factors of malignant pleural mesothelioma and the prognostic value of inflammation indices in malignant pleural mesothelioma. Methods: Between January 2002 and December 2019, a total of 132 patients (74 males, 58 females; mean age: 55 years; range, 31 to 79 years) diagnosed with malignant pleural mesothelioma were retrospectively analyzed. Patients' demographic data and laboratory results were recorded. The prognostic value of the following five inflammation indices was evaluated: neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, advanced lung cancer inflammation index, C-reactive protein/albumin ratio, and prognostic nutritional index. Results: Of all patients, 81% (n=107) were aged 65 or older and 61.4% (n=81) had an epithelioid histology. Of 12 variables examined in the multivariate analysis for their relationship with survival, age >= 65 years, non-epithelioid subtype, and prognostic nutritional index <40 were found to be poor prognostic factors. Based on the score constructed from these factors, the good prognostic group (score 0-1) had a median overall survival of 21 months and a one-year survival rate of 77.9%, while the poor prognostic group (score 2-3) had a median overall survival of nine months and a one-year survival rate of 29.7%. Conclusion: Our study results indicate that age >= 65 years, prognostic nutritional index <40, and non-epithelioid histological subtype are poor prognostic factors of malignant pleural mesothelioma.
引用
收藏
页码:105 / 115
页数:11
相关论文
共 50 条
  • [21] Contemporary Analysis of Prognostic Factors in Patients with Unresectable Malignant Pleural Mesothelioma (MPM)
    Bille, Andrea
    Zauderer, Marjorie
    Woo, Kaitlin
    Rusch, Valerie W.
    Krug, Lee M.
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S404 - S404
  • [22] Prognostic factors in elderly patients with malignant pleural mesothelioma: results of a multicenter survey
    Ceresoli, G. L.
    Grosso, F.
    Zucali, P. A.
    Mencoboni, M.
    Pasello, G.
    Ripa, C.
    Degiovanni, D.
    Simonelli, M.
    Bruzzone, A.
    Dipietrantonj, C.
    Piccolini, E.
    Beretta, G. D.
    Favaretto, A. G.
    Giordano, L.
    Santoro, A.
    Botta, M.
    BRITISH JOURNAL OF CANCER, 2014, 111 (02) : 220 - 226
  • [23] Prognostic and Predictive Factors Affecting Course of Disease and Survival in Malignant Pleural Mesothelioma
    De Palma, Angela
    Loizzi, Michele
    Prisciandaro, Elena
    Pizzuto, Ondina
    Pezzuto, Federica
    Punzi, Alessandra
    Scattone, Anna
    Marzullo, Andrea
    Serio, Gabriella
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S1376 - S1377
  • [24] Prognostic factors and treatment outcomes of malignant pleural mesothelioma in Eastern Asian patients - A Taiwanese study
    Wu, Ting-Hui
    Lee, Lukas Jyuhn-Hsiarn
    Yuan, Chang-Tsu
    Chen, Tom Wei-Wu
    Yang, James Chih-Hsin
    JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2019, 118 (01) : 230 - 236
  • [25] Development of a Novel Prognostic Risk Classification System for Malignant Pleural Mesothelioma
    Doi, Hiroshi
    Kuribayashi, Kozo
    Kitajima, Kazuhiro
    Yamakado, Koichiro
    Kijima, Takashi
    CLINICAL LUNG CANCER, 2020, 21 (01) : 66 - +
  • [26] Extrapleural pneumonectomy for malignant pleural mesothelioma: Outcomes of treatment and prognostic factors
    Yan, Tristan D.
    Boyer, Michael
    Tin, Mo Mo
    Wong, Daniel
    Kennedy, Catherine
    McLean, Jocelyn
    Bannon, Paul G.
    McCaughan, Brian C.
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2009, 138 (03) : 619 - 624
  • [27] Prognostic significance of inflammation-related and electrolyte laboratory variables in patients with malignant pleural mesothelioma
    Zhang, Yuan
    Li, Jie
    Zhang, Shu
    FRONTIERS IN MEDICINE, 2023, 10
  • [28] The Prognostic Role of TNM Staging Compared With Tumor Volume and Number of Pleural Sites in Malignant Pleural Mesothelioma
    Proto, Claudia
    Signorelli, Diego
    Mallone, Sandra
    Prelaj, Arsela
    Lo Russo, Giuseppe
    Imbimbo, Martina
    Galli, Giulia
    Ferrara, Roberto
    Ganzinelli, Monica
    Leuzzi, Giovanni
    Greco, Francesca Gabriella
    Calareso, Giuseppina
    Botta, Laura
    Gatta, Gemma
    Garassino, Marina
    Trama, Annalisa
    CLINICAL LUNG CANCER, 2019, 20 (06) : E652 - E660
  • [29] A Clinical, Radiographic and Laboratory Evaluation of Prognostic Factors in 363 Patients with Malignant Pleural Mesothelioma
    Tanrikulu, Abdullah Cetin
    Abakay, Abdurrahman
    Kaplan, Mehmet Ali
    Kucukoner, Mehmet
    Palanci, Yilmaz
    Evliyaoglu, Osman
    Sezgi, Cengizhan
    Sen, Hadice
    Carkanat, Ali Ihsan
    Kirbas, Gokhan
    RESPIRATION, 2010, 80 (06) : 480 - 487
  • [30] Aquaporin 1 is an independent prognostic factor in pleural malignant mesothelioma
    Kao, Steven Chuan-Hao
    Armstrong, Nicola
    Condon, Bridget
    Griggs, Kim
    McCaughan, Brian
    Maltby, Sarah
    Wilson, Alan
    Henderson, Douglas W.
    Klebe, Sonja
    CANCER, 2012, 118 (11) : 2952 - 2961